Mark E. Fitzgerald
Mark E. Fitzgerald publishes mostly in Molecular Biology, Organic Chemistry and Computational Theory and Mathematics, on topics such as Protein Degradation and Inhibitors, Ubiquitin and proteasome pathways and Computational Drug Discovery Methods.
- World rank
- #2,915,320 of 7,710,434 ranked researchers
- Rank in United States
- #840,834 of 1,627,098
- Works
- 32
- Citations
- 1.1k
- Citations per work
- 34.6
What does Mark E. Fitzgerald research?
Mark E. Fitzgerald's work is mostly in Biochemistry, Genetics and Molecular Biology (49%), Chemistry (20%), Medicine (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1649.4%
- Physical Sciences826.0%
- Chemistry619.5%
- Computer Science26.5%
- Everything else515.5%
- Health Sciences39.1%
- Medicine39.1%
- 1Molecular Biology47% of their works
- 2Organic Chemistry20% of their works
- 3Computational Theory and Mathematics6% of their works
- 4Hematology5% of their works
- 5Public Health, Environmental and Occupational Health4% of their works
- 6Cell Biology3% of their works
Research topics
Which keywords describe Mark E. Fitzgerald's research?
The keywords of their largest research topics: BET Bromodomains, Cancer Therapy, PROTACs, Proteasome Inhibitors, Medicinal Chemistry, Proteasome, Ubiquitin and Molecular Docking.
- Drug Discovery
- Amination
- Olefin Metathesis
- International Myeloma Working Group
- BRAF gene
- Molecular Docking
- Proteasome
- Proteasome Inhibitors
- Cancer Therapy
- BET Bromodomains
- PROTACs
- Medicinal Chemistry
- Ubiquitin
- Virtual Screening
- Diagnosis Criteria
- MAP Kinase
- Ruthenium Catalysts
- Catalytic
- Peptide Synthesis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- BET Bromodomains121 topic
- Cancer Therapy122 topics
- PROTACs121 topic
- Proteasome Inhibitors122 topics
- Medicinal Chemistry82 topics
- Proteasome81 topic
- Ubiquitin81 topic
- Molecular Docking51 topic
- Virtual Screening51 topic
- BRAF gene41 topic
- Diagnosis Criteria41 topic
- International Myeloma Working Group41 topic
- MAP Kinase41 topic
- Olefin Metathesis41 topic
- Ruthenium Catalysts41 topic
- Amination31 topic
- Catalytic31 topic
- Drug Discovery31 topic
- Peptide Synthesis31 topic
Where does Mark E. Fitzgerald work?
Mark E. Fitzgerald's main affiliation in the publication record is C4 Therapeutics (United States), United States.
How many publications and citations does Mark E. Fitzgerald have?
OpenAlex counts 32 works and 1,108 citations for Mark E. Fitzgerald, an h-index of 12, ranking #2,915,320 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mark E. Fitzgerald. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.